Hemodynamic effects of angiotensin II in the kidney

Contributions to Nephrology

Volumn 135, Issue , 2001, Pages 34-46

  Toke, Anitha ^a   Meyer, Timothy W ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II;

ANIMAL; DISEASE MODEL; DRUG EFFECT; HEMODYNAMICS; HUMAN; KIDNEY; METABOLISM; PHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENSITIVITY AND SPECIFICITY; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; DISEASE MODELS, ANIMAL; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; RATS; RENIN-ANGIOTENSIN SYSTEM; SENSITIVITY AND SPECIFICITY; VASOCONSTRICTION;

EID: 0035538351     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060155     Document Type: Article

References (42)

1. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.
2. Seidelin PH, McMurray JJ, Struthers AD: Mechanisms of the antinatriuretic action of physiological doses of angiotensin II in man. Clin Sci 1989;76:653-658.
3. Brenner BM, Schor N, Ichikawa I: Role of angiotensin II in the physiologic regulation of glomerular filtration. Am J Cardiol 1982;49:1430-1433.
4. Blantz RC, Konnen KS, Tucker BJ: Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 1976;57:419-434.
5. Conger JD, Falk SA: KCl and angiotensin responses in isolated rat renal arterioles: effects of diltiazem and low-calcium medium. Am J Physiol 1993;264:F134-F140.
6. Haley DP, Sarrafian M, Bulger RE, Dobyan DC, Eknoyan G: Structural and functional correlates of effects of angiotensin-induced changes in rat glomerulus. Am J Physiol 1987;253:F111-F119.
7. Pagtalunan ME, Rasch R, Rennke HG, Meyer TW: Morphometric analysis of effects of angiotensin II on glomerualr structure in rats. Am J Physiol 1995;268:F82-F88.
8. Olivetti G, Giacomelli F, Wiener J: Morphometry of superficial glomeruli in acute hypertension in the rat. Kidney Int 1985;27:31-38.
9. Loon N, Shemesh O, Morelli E, Myers BD: Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol 1989;257:F608-F614.
10. Bohrer MP, Deen WM, Robertson CR, Brenner BM: Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 1977;233:F13-F21.
11. Miller PL, Rennke HG, Meyer TW: Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 1991;261:F459-F465.
12. Manning RD, Hu L, Mizelle HL, Granger JP: Role of nitric oxide in long-term angiotensin II-induced renal vasoconstriction. Hypertension 1993;21:949-955.
13. Vos PF, Boer P, Koomans HA: Effects of enalapril on renal sodium handling in healthy subjects on low, intermediate, and high sodium intake. J Cardiovasc Pharmacol 1993;22:27-32.
14. Doig JK, MacFadyen RJ, Sweet CS, Reid JL: Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers. J Cardiovasc Pharmacol 1995;25:511-517.
15. Ito S, Amin J, Ren Y, Arima S, Abe K, Carretero O: Heterogeneity of angiotensin action in renal circulation. Kidney Int 1997;52:S128-S131.
16. Persson P, Ehmke H, Kirchheim H: Influence of the renin-angiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs. Acta Physiol Scand 1988;134:1-7.
17. Wang CT, Chin SY, Navar LG: Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol 2000;279:F319-F325.
18. Bidani AK, Schwartz MM, Lewis EJ: Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol 1987;252:F1003-F1010.
19. Schnermann J, Traynor T, Yang T, Arend L, Huang YG, Smart A, Briggs JP: Tubuloglomerular feedback: New concepts and developments. Kidney Int 1998;67:S40-S45.
20. Traynor TR, Schnermann J: Renin-angiotensin system dependence of renal hemodynamics in mice. J Am Soc Nephrol 1999;10:S184-S188.
21. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981;241: F85-F93.
22. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
23. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
24. Baboolal K, Meyer TW: The effect of acute angiotensin II blockade on renal function in rats with reduced renal mass. Kidney Int 1994;46:980-985.
25. Rosenberg ME, Smith LJ, Corea-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 1994;45:403-410.
26. Mackie FE, Campbell DJ, Meyer TW: Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency. Kidney Int 2001;59:1458-1465.
27. Meyer TW, Rennke HG: Progressive glomerular injury following limited renal infarction in the rat. Am J Physiol 1988;254:F856-F862.
28. Griffin KA, Picken M, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Neprhol 1994;4:2023-2031.
29. Guan S, Fox J, Mitchell KD, Navar LG: Angiotensin and angiotensin converting enzyme tissue levels in two kidney, one clip hypertensive rats. Hypertension 1992;20:763-767.
30. Von Thun AM, Vari RC, El-Dahr SS, Navar LG: Augmentation of intrarenal angiotensin II levels by chronic Ang II infusion. Am J Physiol 1994;266:F120-F128.
31. Verhagen AMG, Braam B, Boer P, Grone H-J, Koomans HA, Joles JA: Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations. Kidney Int 1999;56:222-231.
32. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-415.
33. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner, BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
34. Campbell DJ, Kelly DJ, Wilkinson-Berka JL, Cooper ME, Skinner SL: Increased bradykinin and 'normal' angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats. Kidney Int 1999;56:211-221.
35. Gansevoort RT, De Zeeuw D, De Jong PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994;45:861-867.
36. Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH: Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy Kidney Int 2000;57:601-606.
37. Agodoa LY, Appel L, Bakris GK, et al: Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA 2001;285:2719-2728.
38. Pechere-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M: Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens 1998;16:385-393.
39. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH: Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 1995;7:1726-1731.
40. Apperloo AJ, de Zeeuw D, de Jong PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 1997;51:793-797.
41. Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, Cooper ME: Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000;321:1440-1444.
42. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989;36:272-279.